# Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer

> **NCT06353061** · PHASE2 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 51 (estimated)

## Conditions studied

- Cervical Cancer
- Radiotherapy
- Metformin
- Hypoxia
- PET/CT

## Interventions

- **DRUG:** Metformin
- **RADIATION:** Radiotherapy
- **DRUG:** Chemotherapy
- **DIAGNOSTIC_TEST:** PET/CT

## Key facts

- **NCT ID:** NCT06353061
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-15
- **Primary completion:** 2025-08-01
- **Final completion:** 2026-02-01
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2025-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06353061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06353061, "Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06353061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
